Loading...
NPI 1174185649 · Tucson, AZ · Ambulatory Surgical Clinic/Center
Customize your policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
Pisa Asc Holdco LLC is a ambulatory surgical clinic/center provider located in Tucson, Arizona. This profile covers 22 Medicare and 6 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Organization |
| Organization | Pisa Asc Holdco LLC |
| Address | 4741 E Camp Lowell Drive |
| City | Tucson |
| State | AZ |
| ZIP | 85712 |
| Taxonomy | Ambulatory Surgical Clinic/Center |
| NPI Enumerated | July 3, 2019 |
Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)
| Payer Source | Total Paid |
|---|---|
| Medicare | $4.6M |
| Medicaid | $140K |
PISA ASC HOLDCO LLC’s billed services center on neuromodulation and interventional pain procedures consistent with its Ambulatory Surgical Clinic/Center taxonomy; the Medicare top codes 63685, 63650, and 64555 reflect spinal and peripheral neurostimulator implantation and lead placement while the broader CPT mix includes high-volume epidural, facet, and sacroiliac joint injections. High average paid/claim values for implant codes (e.g., 63685 $17872 avg paid/claim, 64590 $13986 avg paid/claim) alongside numerous image-guided injection codes indicate an ASC workflow built around device implantation plus image-guided pain interventions.
Revenue is highly concentrated within a small set of procedures: the provider’s top three Medicare codes (63685, 63650, 64555) account for 59.2% of its total Medicare revenue, and the top three Medicaid codes (62323, 64483, G0260) account for 76.3% of its total Medicaid revenue. This concentration suggests the facility’s financial performance is strongly tied to a narrow set of neuromodulation and interventional spine services.
Payer mix is heavily Medicare-skewed: lifetime Medicare revenue totals $4.6M versus $140K in Medicaid revenue, indicating Medicare is the dominant public payer for this ASC and Medicaid represents a small share of the recorded public-payer billing. Analysts should treat Medicaid activity as a relatively minor component of total public-payer volume when modeling payer risk or reimbursement exposure.
On national competitive standing for key implant codes, PISA ASC HOLDCO LLC is an unusually high-volume provider: 64555 ranks #2 of 211 providers nationally (100th percentile; extreme outlier) and 63650 ranks #19 of 1371 providers nationally (99th percentile; extreme outlier), while 63685 ranks #25 of 1281 (98th percentile; notably above typical national volume). These ranks indicate the ASC is a major national outlier for specific neuromodulation procedures rather than a low-volume, typical ASC for those services.
Beyond implants, the facility also shows extreme or notable national volume for multiple image-guided pain procedures: 64635 ranks #8 of 5957 providers (100th percentile; extreme outlier), 64493 ranks #13 of 7519 (100th percentile; extreme outlier), and 64483 ranks #60 of 8202 (99th percentile; extreme outlier). This pattern signals a dual service line of high-volume neurostimulation implants plus concentrated interventional pain interventions, which may attract specialist referrals for complex pain management.
Medicaid competitive standing is more modest and more variable in-state: the leading Medicaid code 62323 ranks #11 of 41 providers in-state (75th percentile; typical, unremarkable volume), 64483 ranks #42 of 77 (46th percentile; typical, unremarkable volume), and G0260 ranks #7 of 10 (33rd percentile; typical, unremarkable volume). In-state Medicaid positioning suggests the ASC is not a dominant Medicaid provider for these services and that its Medicaid role is operationally secondary to its Medicare business.
Tenure information shows the entity’s NPI was enumerated on 2019-07-03 (~7 years ago), indicating several years of billing history in Medicare and Medicaid datasets; the observed volume and specialty concentration have been established within that operational window. This relative recency combined with high national ranks for select codes may reflect a focused growth strategy around neuromodulation and interventional spine procedures since enumeration.
From a utilization perspective, the provider displays multiple labeled statistical outliers across code types rather than a uniform elevation across all services: specific implant and neurolytic codes are characterized as "extreme outlier" or "notably above typical" in national comparisons, whereas many other injection codes show typical or unremarkable volumes. Analysts should interpret the ASC as highly specialized with outlier-level activity in a discrete set of high-revenue neuromodulation and pain-intervention codes rather than a broadly high-volume multimodal surgery center.
Medicare revenue breakdown by CPT/HCPCS procedure code.
View: Bar Chart1 / 2
The CPT/HCPCS codes generating the most Medicare revenue for this provider.
22 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 63685 | The provider inserts or replaces a spinal neurostimulator pulse generator or receiver. The system is one that requires surgical creation of a pocket for placement and that requires a connection… | 70 | $17,870 | $1.2M |
| 63650 | In this procedure, the provider places electrodes in the epidural space to relieve pain and reduce or eliminate spasms. | 230 | $3,550 | $827.6K |
| 64555 | A neurostimulator includes electrodes which are inserted under the skin and induced by a generator to stimulate the nerve tissue. Use of this stimulator involves implantation of electrodes around a… | 180 | $3,920 | $685.8K |
| 64590 | The provider inserts or replaces a peripheral, sacral, or gastric neurostimulator pulse generator or receiver. The system is one that requires surgical creation of a pocket for placement and that… | 30 | $13,990 | $419.6K |
| 0275T | N/A | 90 | $3,470 | $305.5K |
| 64635 | Under fluoroscopic or CT guidance, the provider applies an agent to a lower back joint to destroy nerve tissue. | 530 | $470 | $253.1K |
| 64483 | This procedure is the injection of an anesthetic agent and/or steroid in the form of a transforaminal epidural injection into a single level (either lumbar or sacral). | 790 | $260 | $208K |
| 64493 | The provider injects a diagnostic or therapeutic substance into a single lumbar or sacral paravertebral facet (zygapophyseal) joint, or into the nerves that supply that joint, using imaging guidance… | 760 | $250 | $185.5K |
| G0260 | Injection procedure for sacroiliac joint; provision of anesthetic, steroid and/or other therapeutic agent, with or without arthrography | 600 | $200 | $119.8K |
| 64633 | In this procedure, the provider destroys the facet joint nerve of a cervical or thoracic spinal segment using neurolytic agents like heat, electric current, or a chemical compound. He makes use of… | 170 | $580 | $99.8K |
Showing 1–10 of 22
How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 22 CPT/HCPCS codes.
View: State1 / 2
Full comparison — all codes billed, vs. state median
22 rows
| CPT/HCPCS Code | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|
| 63685 | 1 | 70 | 20 | $10,020 | $200.4K |
| 64590 | 5 | 30 | 20 | $7,000 | $189K |
| 64555 | 1 | 10 | 60 | $2,020 | $147.8K |
| 63650 | 1 | 70 | 40 | $2,040 | $116K |
| 0275T | 1 | 20 | 20 | $2,460 | $51.6K |
| 64483 | 5 | 250 | 90 | $210 | $31K |
| 64635 | 1 | 210 | 60 | $390 | $30.3K |
| G0260 | 1 | 40 | 60 | $210 | $22.9K |
| 64493 | 1 | 220 | 70 | $190 | $18.8K |
| 64633 | 1 | 140 | 30 | $380 | $13.2K |
Showing 1–10 of 22
Medicaid revenue breakdown by year and by CPT/HCPCS procedure code, including monthly billing trends and the top codes driving revenue.
View: By Year1 / 3
Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.
6 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 62323 | The provider injects a diagnostic or a therapeutic substance, such as pain medication or a steroid, into the space around the spinal nerves of the lumbar (lower back) or sacral (caudal, or tailbone)… | 310 | $150 | $44.4K |
| 64483 | This procedure is the injection of an anesthetic agent and/or steroid in the form of a transforaminal epidural injection into a single level (either lumbar or sacral). | 280 | $130 | $37.4K |
| G0260 | Injection procedure for sacroiliac joint; provision of anesthetic, steroid and/or other therapeutic agent, with or without arthrography | 150 | $170 | $25.1K |
| 64493 | The provider injects a diagnostic or therapeutic substance into a single lumbar or sacral paravertebral facet (zygapophyseal) joint, or into the nerves that supply that joint, using imaging guidance… | 140 | $170 | $22.9K |
| 64635 | Under fluoroscopic or CT guidance, the provider applies an agent to a lower back joint to destroy nerve tissue. | 40 | $220 | $8.1K |
| 64490 | The provider injects a diagnostic or therapeutic substance into a single cervical or thoracic paravertebral facet (zygapophyseal) joint, or into the nerves that supply that joint, using imaging… | 20 | $130 | $2.1K |
How this provider's Medicaid billing volume and revenue compare to other Arizona providers billing the same CPT/HCPCS codes.
Full comparison — all codes billed, vs. Arizona median
6 rows
| CPT/HCPCS Code | Description | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|---|
| 64635 | Under fluoroscopic or CT guidance, the provider applies an agent to a lower back joint to destroy nerve tissue. | 35 | 40 | 330 | $220 | $294.9K |
| 64483 | This procedure is the injection of an anesthetic agent and/or steroid in the form of a transforaminal epidural injection into a single level (either lumbar or sacral). | 42 | 80 | 350 | $160 | $259.1K |
| 64493 | The provider injects a diagnostic or therapeutic substance into a single lumbar or sacral paravertebral facet (zygapophyseal) joint, or into the nerves that supply that joint, using imaging guidance… | 33 | 60 | 240 | $140 | $133.3K |
| 64490 | The provider injects a diagnostic or therapeutic substance into a single cervical or thoracic paravertebral facet (zygapophyseal) joint, or into the nerves that supply that joint, using imaging… | 20 | 20 | 140 | $140 | $105.5K |
| G0260 | Injection procedure for sacroiliac joint; provision of anesthetic, steroid and/or other therapeutic agent, with or without arthrography | 7 | 10 | 280 | $160 | $68.3K |
| 62323 | The provider injects a diagnostic or a therapeutic substance, such as pain medication or a steroid, into the space around the spinal nerves of the lumbar (lower back) or sacral (caudal, or tailbone)… | 11 | 40 | 120 | $130 | $59.2K |
Other providers in the same ZIP code as Pisa Asc Holdco LLC, ranked by combined Medicare and Medicaid revenue.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.